Voices
Xiuning Le
Xiuning Le/LinkedIn

Xiuning Le: Celebrating FDA Approval of Sevabertinib for HER2-Mutant NSCLC

Xiuning Le, Associate Professor, Deputy Section Chief of Thoracic Medical Oncology at MD Anderson Cancer Center, shared a post on LinkedIn:

“We celebrate sevabertinib FDA approval for HER2 mutation NSCLC with lab members and clinical research staff! To the very curious Dominik Ruettinger. It is a mango mousse cake, which is edible, in fact, delicious.”

FDA

More posts featuring Xiuning Le on OncoDaily.

cancer Dominik Ruettinger FDA NSCLC OncoDaily Oncology Xiuning Le